stars 1 stars 2 stars 3

ReverTech is developing ExCEP the world’s first automatic intestinal prosthesis ensuring artificially intestinal continuity for patients with a temporary double enterostomy before stoma reversal. ExCEP preserves the intestinal physiology, allows the absorption of nutrients and water, and prevents complications after stoma closure.

ReverTech Questions

Thierry Melon is the Directeur technique of ReverTech.

6 people are employed at ReverTech.

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users